Adenocarcinoma of the stomach: a review.
作者信息
McLoughlin James M
机构信息
Department of Surgery, Baylor University Medical Center, Dallas, Texas 75246, USA.
出版信息
Proc (Bayl Univ Med Cent). 2004 Oct;17(4):391-9. doi: 10.1080/08998280.2004.11928001.
Abstract
摘要
相似文献
1
Adenocarcinoma of the stomach: a review.
Proc (Bayl Univ Med Cent). 2004 Oct;17(4):391-9. doi: 10.1080/08998280.2004.11928001.
2
Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review.
J Clin Pathol. 2004 Apr;57(4):428-31. doi: 10.1136/jcp.2003.013946.
3
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.
4
[Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Zhonghua Wei Chang Wai Ke Za Zhi. 2007 May;10(3):245-8.
5
6
[Clinico-pathological sessions: mucoid adenocarcinoma of the lesser curvature of the stomach].
Arq Clin (Rio De J). 1951 Mar;12(3):225-32.
7
Single-institute comparison of the efficacy of systemic chemotherapy for oesophagogastric junction adenocarcinoma and stomach adenocarscinoma in a metastatic setting.
ESMO Open. 2020 Apr;5(2). doi: 10.1136/esmoopen-2019-000595.
8
Loss of heterozygosity at chromosomes 1p35-pter, 4q, and 18q and protein expression differences between adenocarcinomas of the distal stomach and gastric cardia.
Hum Pathol. 2012 Dec;43(12):2308-17. doi: 10.1016/j.humpath.2012.01.024. Epub 2012 Aug 16.
9
Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.
World J Surg. 2006 Oct;30(10):1864-9. doi: 10.1007/s00268-005-0582-z.
10
The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989.
Cancer. 1993 Jul 15;72(2):330-40. doi: 10.1002/1097-0142(19930715)72:2<330::aid-cncr2820720205>3.0.co;2-l.
引用本文的文献
1
The Effect of Extended Dissection of Lymph Nodes (D2plus) with Gastrectomy on the Clinical and Oncological Outcomes in Gastric Cancer Patients, Compared to a Standard Dissection (D2).
Medicina (Kaunas). 2025 Jul 16;61(7):1284. doi: 10.3390/medicina61071284.
2
The Prediagnostic General Practitioners' Pathway of Gastrointestinal Stromal Tumor Patients: A Real-World Data Study.
Cancers (Basel). 2025 Apr 22;17(9):1391. doi: 10.3390/cancers17091391.
3
Synchronous Hepatocellular Carcinoma in a Patient with Primary Gastric Cancer: An Exceptional Association.
Case Rep Gastroenterol. 2020 May 28;14(2):299-305. doi: 10.1159/000506188. eCollection 2020 May-Aug.
4
Metastatic gastric adenocarcinoma and synchronous carcinoid tumour mimicking appendicitis: A case report.
Int J Surg Case Rep. 2018;44:93-97. doi: 10.1016/j.ijscr.2018.02.023. Epub 2018 Feb 16.
5
Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage.
Gastric Cancer. 2015 Jul;18(3):571-9. doi: 10.1007/s10120-014-0410-y. Epub 2014 Aug 7.
6
Pathological factors affecting gastric adenocarcinoma survival in a Caribbean population from 2000-2010.
World J Gastrointest Surg. 2014 Jun 27;6(6):94-100. doi: 10.4240/wjgs.v6.i6.94.
7
A case of gastric adenocarcinoma in a Shih Tzu dog: successful treatment of early gastric cancer.
J Vet Med Sci. 2014 Jul;76(7):1033-8. doi: 10.1292/jvms.13-0315. Epub 2014 Mar 20.
8
Measuring patient-reported outcomes in advanced gastric cancer.
Ecancermedicalscience. 2013 Sep 16;7:351. doi: 10.3332/ecancer.2013.351. eCollection 2013.
9
Common primary tumours of the abdomen and pelvis and their patterns of tumour spread as seen on multi-detector computed tomography.
Insights Imaging. 2011 Jun;2(3):205-214. doi: 10.1007/s13244-011-0089-0. Epub 2011 Apr 14.
本文引用的文献
1
Different expression of Bcl-2 in diffuse and intestinal type stomach carcinomas.
Oncol Rep. 1996 Sep;3(5):825-8. doi: 10.3892/or.3.5.825.
2
Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy.
Oncology (Williston Park). 2004 Feb;18(2):207-19; discussion 220-2, 227-8, 230.
3
Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options.
Oncology (Williston Park). 2004 Jan;18(1):51-9.
4
Prognostic significance of metastatic lymph node size in patients with gastric cancer.
Br J Surg. 2003 Dec;90(12):1522-30. doi: 10.1002/bjs.4354.
5
Chemotherapy in the management of gastric cancer.
J Clin Oncol. 2003 Dec 1;21(23 Suppl):276s-279s. doi: 10.1200/JCO.2003.09.137.
6
Principles of surgical treatment for curable gastric cancer.
J Clin Oncol. 2003 Dec 1;21(23 Suppl):274s-275s. doi: 10.1200/JCO.2003.09.172.
7
Improving treatment outcome for gastric cancer: the role of surgery and adjuvant therapy.
J Clin Oncol. 2003 Dec 1;21(23 Suppl):272s-273s. doi: 10.1200/JCO.2003.09.136.
8
Are carcinomas of the cardia oesophageal or gastric adenocarcinomas?
Eur J Cancer. 2003 Nov;39(17):2487-94. doi: 10.1016/s0959-8049(03)00664-6.
9
Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.
Cancer Lett. 2003 Nov 10;201(1):97-106. doi: 10.1016/j.canlet.2003.07.007.
10
Impact of perioperative intraperitoneal chemotherapy on the treatment of primary gastric cancer.
Surg Oncol Clin N Am. 2003 Jul;12(3):623-34, xi. doi: 10.1016/s1055-3207(03)00025-5.
Zotero 插件